These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 16517112

  • 1. Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up.
    Mhawech-Fauceglia P, Fischer G, Beck A, Cheney RT, Herrmann FR.
    Eur J Surg Oncol; 2006 May; 32(4):439-44. PubMed ID: 16517112
    [Abstract] [Full Text] [Related]

  • 2. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
    Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S.
    Pathol Res Pract; 2011 Mar 15; 207(3):161-3. PubMed ID: 21247708
    [Abstract] [Full Text] [Related]

  • 3. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
    Denzinger S, Stoehr R, Schwarz S, Eichenseher N, Brockhoff G, Obermann EC, Knuechel R, Blaszyk H, Hartmann A, Wild PJ.
    Int J Oncol; 2007 Oct 15; 31(4):793-802. PubMed ID: 17786310
    [Abstract] [Full Text] [Related]

  • 4. Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis.
    Mhawech-Fauceglia P, Fischer G, Alvarez V, Ahmed A, Herrmann FR.
    BJU Int; 2007 Nov 15; 100(5):1182-7. PubMed ID: 17645415
    [Abstract] [Full Text] [Related]

  • 5. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
    Mhawech-Fauceglia P, Alvarez V, Fischer G, Beck A, Herrmann FR.
    Am J Clin Pathol; 2008 Jun 15; 129(6):918-23. PubMed ID: 18480009
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study.
    Cai T, Piazzini M, Nesi G, Taddei I, Sardi I, Detti B, Mondaini N, Dal Canto M, Bartoletti R.
    Oncol Rep; 2007 Apr 15; 17(4):925-30. PubMed ID: 17342338
    [Abstract] [Full Text] [Related]

  • 7. The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.
    Schultz IJ, Kiemeney LA, Roelofs R, Van Aarssen Y, Babjuk M, Willems JL, Malmström PU, Swinkels DW, Witjes JA, De Kok JB.
    Anticancer Res; 2007 Apr 15; 27(2):1025-30. PubMed ID: 17465238
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.
    Eur Urol; 2006 May 15; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [Abstract] [Full Text] [Related]

  • 9. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H.
    Eur Urol; 2004 Jun 15; 45(6):737-43. PubMed ID: 15149745
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
    Mhawech-Fauceglia P, Ali L, Cheney RT, Groth J, Herrmann FR.
    J Clin Pathol; 2009 Aug 15; 62(8):710-4. PubMed ID: 19638542
    [Abstract] [Full Text] [Related]

  • 11. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H.
    Clin Cancer Res; 2006 May 01; 12(9):2780-7. PubMed ID: 16675571
    [Abstract] [Full Text] [Related]

  • 12. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
    Mahnken A, Kausch I, Feller AC, Krüger S.
    Oncol Rep; 2005 Oct 01; 14(4):1065-70. PubMed ID: 16142373
    [Abstract] [Full Text] [Related]

  • 13. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
    Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A.
    Cancer; 2002 Sep 15; 95(6):1247-57. PubMed ID: 12216092
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K, Oda Y, Kinukawa N, Naito S, Tsuneyoshi M.
    Hum Pathol; 2005 May 15; 36(5):522-30. PubMed ID: 15948119
    [Abstract] [Full Text] [Related]

  • 15. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.
    Clairotte A, Lascombe I, Fauconnet S, Mauny F, Félix S, Algros MP, Bittard H, Kantelip B.
    Am J Clin Pathol; 2006 Jan 15; 125(1):119-26. PubMed ID: 16483000
    [Abstract] [Full Text] [Related]

  • 16. Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer.
    Compérat E, Bièche I, Dargère D, Laurendeau I, Vieillefond A, Benoit G, Vidaud M, Camparo P, Capron F, Verret C, Cussenot O, Bedossa P, Paradis V.
    Urology; 2008 Oct 15; 72(4):873-7. PubMed ID: 18485461
    [Abstract] [Full Text] [Related]

  • 17. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E.
    Hum Pathol; 2005 Aug 15; 36(8):899-907. PubMed ID: 16112007
    [Abstract] [Full Text] [Related]

  • 18. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
    Fraizer GC, Diaz MF, Lee IL, Grossman HB, Sen S.
    Int J Oncol; 2004 Dec 15; 25(6):1631-9. PubMed ID: 15547700
    [Abstract] [Full Text] [Related]

  • 19. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.
    Urology; 2004 Jun 15; 63(6):1198-204. PubMed ID: 15183989
    [Abstract] [Full Text] [Related]

  • 20. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ, Fox SB, Newcomb PV, Persad RA, Sibley GN, Harris AL.
    J Urol; 1995 Jul 15; 154(1):237-41. PubMed ID: 7776437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.